Drug Induced Cardiac Doses Flashcards

1
Q

What is the diagnostic criteria for someone to have drug induced QT prolongation?

A

QT >500 or QT> 60 from baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the common drug classes that cause QT prolongation?

ABCDEF

A

AntiArrythmics-amiodarone, dofetilide, sotalol
AntiBiotics-fluoroquinolones and macrolides
AntipsyChotics-first gen worse than second gen
AntiDepressants-citalopram and TCA
AntiEmetics-ondansetron
AntiFungals-azoles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the non modifiable risk factors for torsades de pointes

A

Over 65
Female
Genetic predisposition
Cardiac disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the modifiable risk factors for torsades de pointes

A

Diuretic treatment
Electrolyte abnormalities
Taking More than one QT prolonging agent
Organ function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some ways to approach Drug induced QT prolongation?

A

Avoid QT prolongating drugs in pts with pretreatment intervals> 450

Reduce dose or d/c prolonging agents if qt incr >/= 60 from baseline

D/c prolonging agent if qt incr to 500

Maintain k>4 and mg>2

Avoid concomitant administration of qt prolonging drugs

Avoid use of qt prolonging drugs in a pt with a history of drug induced torsades de pointes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the general treatment regimen of drug induced qt prolongation

A
  1. D/c offending agents
  2. NO PULSE-give mg PUSH
    PULSE- give mg infusion
  3. Transcutaneous pacing
  4. Isoporoteronol infusion
  5. Cardio version or defibrillation if pt is hemodynamically unstable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some alternatives to isoproteronol

A

Epinephrine or atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the three main causes of drug induced heart failure

A
  1. Sodium and volume retention
  2. Direct cardiotoxicity which can lead to cardiomyopathy
  3. Negative ionotropy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug classes that cause sodium and volume retention

A

NSAIDS
STEROIDS
THIAZOLIDINEDIONES-rosiglitazone and pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Drugs that cause cardiomyopathy

A

Chemo agents-anthracyclines (daunorubicin, doxorubicin) and alkylating agents

Biologics **trastuzumab
Alcohol-has direct toxic effect on myocardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs that cause negative ionotropy

A

NON DHP CCB-diltiazem and verapamil
BETA BLOCKERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug class has a BBW to avoid in pts with NYHA CLASS III-IV

A

Thiazolidinediones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chemoprotectant that binds to TOP2B to prevent anthracycline binding

A

Dexaroxane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment related risk factors for anthracycline induced cardiotox/myopathy

A

Cumulative dose more than 400mg/ m2
Dosing schedules
Previous anthracycline therapy
Co-admin of potentially cardiotoxic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Patient related risk factors of anthracycline induced cardiomyopathy

A

Age
Preexisting cardiovascular disease factors
Obesity
Smoking
Possibly gender

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the max lifetime dose of anthracyclines

A

550 mg/m2

17
Q

Risk factors for development of trastuzumab incduced cardiomyopathy

A

Advanced age
Prescence of CV comorbidities
Previous treatment with anthracyclines

18
Q

Is trastuzumab induced cardiomyopathy irreversible

A

NO ITS REVERSIBLE ONCE DRUG IS D/C

19
Q

What is trastuzumab BBW

A

Associated with symptomatic and asymptomatic LVEF and development of HF

20
Q

What monitoring parameter should you evaluate in all patients taking trastuzumab

A

LVEF

21
Q

Treatment regimen for trastuzumab induced cardiomyopathy

A

Adjust dose base on LVEF
Consider decr dose or D/C if HF develops
Consider HF meds during treatment if EF declines (ace/arb and b blockers)

22
Q

Who should avoid non dhp ccb

A

Pts with EF less than 40%

23
Q

Who should avoid beta blockers

A

Pts with acute hf exacerbation

24
Q

What drugs cause hf due to negative ionotropy

A

Non dhp ccb and beta blockers

25
Q

Drugs that cause increased myocardial oxygen demand
(increased hr and contractility)

A

**Cocaine, beta agonists, sympathomimetics, withdrawal of beta blockers, and potent vasodilators

26
Q

Drugs that cause decrease myocardial supply

Increased coronary resistance

A

**Cocaine and triptans

27
Q

Drugs that cause drug induced acs
(Coronary artery thrombosis)

A

**Cocaine, oral contraceptives, **NSAIDS, estrogens, anti migraine agents

28
Q

Drugs that cause drug induced acs
(Increased cardiovascular risk)

A

**Cocaine, estrogens, **NSAIDS, HIV AGENTS, oral contraceptives, rosiglitazone

29
Q

Treatment options for cocaine induced MI

A
  1. Chest pain
    -Aspirin and benzos
    2.persistent HTN
    -benzos and IV nitroglycerin
  2. Long term acs treatment
    -AVOID BETA BLOCKERS
30
Q

BBW that all NSAIDs have

A

Increased risk of severe cardiovascular thrombotic events, MI and stroke which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease may be at greater risk

31
Q

What are the risk factors for acute MI with NSAIDS

A

1.increased risk early on in therapy
2. Use of NSAIDS
3. HIGH DOSE=HIGH RISK
->1200mg/day of ibuprofen
->750mg/day of naproxen

32
Q

T/f non selective NSAIDs have increases risk of MI

A

FALSE there’s no diff btwn selective and non selective